Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Arcellx

Rami Elghandour

Rami Elghandour

Chairman and Chief Executive Officer
David Hilbert

David Hilbert

Founder and Chief Technical Officer
Christopher Heery

Christopher Heery

Chief Medical Officer
Michael Dombeck

Michael Dombeck

Chief Operating Officer
Shashi Kaithamana

Shashi Kaithamana

Vice President, Protein Sciences
Brian Murphy

Brian Murphy

Vice President, Cell Process Sciences
Show more

Arcellx Office Locations

Arcellx has an office in Gaithersburg
Gaithersburg, MD, US (HQ)
25 W Watkins Mill Rd suite a
Show all (1)

Arcellx Financials and Metrics

Summary Metrics

Founding Date

2015

Arcellx total Funding

$200 m

Arcellx latest funding size

$115 m

Time since last funding

9 months ago

Arcellx investors

Arcellx's latest funding round in April 2021 was reported to be $115 m. In total, Arcellx has raised $200 m
Show all financial metrics

Arcellx Cybersecurity Score

Cybersecurity ratingPremium dataset

A

90/100

SecurityScorecard logo

Arcellx Online and Social Media Presence

Embed Graph

Arcellx News and Updates

Arcellx Presents Continued Robust Long-Term Responses from its CART-ddBCMA Phase 1 Expansion Trial in Patients with Relapsed or Refractory Multiple Myeloma at the 63rd ASH Annual Meeting and Exposition

-- Two dose levels studied (100 and 300 million CAR+ T-cells); MTD not reached -- -- 100% ORR at both dose levels; deep and durable responses observed in patients with poor prognostic factors --

Arcellx to Present New Clinical Data from its CART-ddBCMA Phase 1 Trial in Patients with Relapsed and Refractory Multiple Myeloma at the 63rd ASH Annual Meeting and Exposition

GAITHERSBURG, Md., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Arcellx, Inc., a privately held clinical-stage biopharmaceutical company, today announced the presentation of new Phase 1 clinical trial data of its CART-ddBCMA for the treatment of patients with relapsed and refractory multiple myeloma. The pre…

Arcellx Announces Presentation of Positive Clinical Results from Ongoing Phase 1 Study of CART-ddBCMA at the 2021 ASCO Annual Meeting

100% (12/12) of patients with relapsed and refractory multiple myeloma treated with Arcellx’s BCMA-specific CAR-modified T-cell therapy achieved responses per IMWG criteria 100% (12/12) of patients with relapsed and refractory multiple myeloma treated with Arcellx’s BCMA-specific CAR-modified T-cel…

Arcellx to Present Data from Phase 1 Study of CART-ddBCMA Demonstrating Continued Positive Response in Patients with Relapsed and Refractory Multiple Myeloma at the 2021 ASCO Annual Meeting

100% (12/12) overall response rate per IMWG criteria observed across all dose levels 100% (12/12) overall response rate per IMWG criteria observed across all dose levels

Arcellx Closes $115 Million Series C Financing to Advance its Pipeline of Adaptive and Controllable Cell Therapies

GAITHERSBURG, Md., April 13, 2021 (GLOBE NEWSWIRE) -- Arcellx, a privately held clinical-stage biopharmaceutical company, today announced that it raised $115 million in a Series C financing to advance its pipeline of adaptive and controllable cell therapies. The proceeds will support the company’s…

Arcellx Announces FDA Clearance of IND Application for ACLX-001, a Controllable Cell Therapy Utilizing the Company’s ARC-SparX Platform, for the Treatment of Multiple Myeloma

Phase 1 Clinical Trial Expected to Begin in the Second Half of 2021 Phase 1 Clinical Trial Expected to Begin in the Second Half of 2021
Show more

Arcellx Frequently Asked Questions

  • When was Arcellx founded?

    Arcellx was founded in 2015.

  • Who are Arcellx key executives?

    Arcellx's key executives are Rami Elghandour, David Hilbert and Christopher Heery.

  • How many employees does Arcellx have?

    Arcellx has 14 employees.

  • Who are Arcellx competitors?

    Competitors of Arcellx include LIPAC Oncology, Cybrexa Therapeutics and Immutep.

  • Where is Arcellx headquarters?

    Arcellx headquarters is located at 25 W Watkins Mill Rd suite a, Gaithersburg.

  • Where are Arcellx offices?

    Arcellx has an office in Gaithersburg.

  • How many offices does Arcellx have?

    Arcellx has 1 office.